Cytotoxic-free treatment designs: time to resistance

Nat Clin Pract Oncol. 2007 Jan;4(1):1. doi: 10.1038/ncponc0695.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Drug Design
  • Drug Resistance, Neoplasm*
  • ErbB Receptors / antagonists & inhibitors*
  • Humans
  • Neoplasms / drug therapy*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • ErbB Receptors
  • Protein-Tyrosine Kinases